Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 9 studies | 30% ± 12% | |
epithelial cell | 6 studies | 39% ± 17% | |
ciliated cell | 6 studies | 33% ± 14% | |
respiratory goblet cell | 5 studies | 20% ± 4% | |
secretory cell | 5 studies | 25% ± 6% | |
squamous epithelial cell | 4 studies | 60% ± 18% | |
club cell | 4 studies | 34% ± 18% | |
endothelial cell | 3 studies | 16% ± 1% | |
keratinocyte | 3 studies | 23% ± 7% |
Insufficient scRNA-seq data for expression of EPHA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 96% | 9954.16 | 1389 / 1445 | 98% | 160.66 | 180 / 183 |
intestine | 94% | 1887.31 | 904 / 966 | 98% | 108.46 | 517 / 527 |
uterus | 100% | 2899.39 | 170 / 170 | 91% | 130.29 | 417 / 459 |
thymus | 100% | 3264.64 | 653 / 653 | 90% | 65.47 | 545 / 605 |
lung | 99% | 3585.36 | 571 / 578 | 91% | 73.38 | 1048 / 1155 |
bladder | 95% | 2784.38 | 20 / 21 | 94% | 110.43 | 475 / 504 |
stomach | 92% | 2151.41 | 332 / 359 | 97% | 97.23 | 276 / 286 |
kidney | 98% | 2712.35 | 87 / 89 | 86% | 52.69 | 771 / 901 |
pancreas | 86% | 1261.12 | 283 / 328 | 93% | 151.23 | 165 / 178 |
skin | 95% | 5241.02 | 1720 / 1809 | 74% | 47.35 | 348 / 472 |
ovary | 78% | 1033.17 | 141 / 180 | 89% | 49.03 | 382 / 430 |
breast | 100% | 3045.22 | 459 / 459 | 33% | 8.68 | 365 / 1118 |
liver | 89% | 1879.72 | 202 / 226 | 41% | 15.32 | 167 / 406 |
prostate | 97% | 2312.80 | 238 / 245 | 22% | 7.06 | 110 / 502 |
adrenal gland | 98% | 1743.97 | 254 / 258 | 17% | 5.38 | 40 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 238.08 | 1 / 1 |
adipose | 100% | 3482.54 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 1799.74 | 846 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 146.56 | 43 / 45 |
spleen | 94% | 1471.52 | 226 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 91% | 1488.48 | 1209 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 35.30 | 70 / 80 |
brain | 16% | 147.14 | 410 / 2642 | 16% | 4.95 | 113 / 705 |
muscle | 31% | 257.60 | 246 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 3.46 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0048870 | Biological process | cell motility |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0043535 | Biological process | regulation of blood vessel endothelial cell migration |
GO_0070372 | Biological process | regulation of ERK1 and ERK2 cascade |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0033598 | Biological process | mammary gland epithelial cell proliferation |
GO_0060444 | Biological process | branching involved in mammary gland duct morphogenesis |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0007275 | Biological process | multicellular organism development |
GO_0001570 | Biological process | vasculogenesis |
GO_0007155 | Biological process | cell adhesion |
GO_1903348 | Biological process | positive regulation of bicellular tight junction assembly |
GO_0045765 | Biological process | regulation of angiogenesis |
GO_0046058 | Biological process | cAMP metabolic process |
GO_0002043 | Biological process | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0060035 | Biological process | notochord cell development |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0030182 | Biological process | neuron differentiation |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_1901491 | Biological process | negative regulation of lymphangiogenesis |
GO_0046849 | Biological process | bone remodeling |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0036342 | Biological process | post-anal tail morphogenesis |
GO_0014028 | Biological process | notochord formation |
GO_0033628 | Biological process | regulation of cell adhesion mediated by integrin |
GO_0070309 | Biological process | lens fiber cell morphogenesis |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0032682 | Biological process | negative regulation of chemokine production |
GO_0048320 | Biological process | axial mesoderm formation |
GO_0001501 | Biological process | skeletal system development |
GO_1904238 | Biological process | pericyte cell differentiation |
GO_0021915 | Biological process | neural tube development |
GO_0070848 | Biological process | response to growth factor |
GO_0016477 | Biological process | cell migration |
GO_0060326 | Biological process | cell chemotaxis |
GO_0010591 | Biological process | regulation of lamellipodium assembly |
GO_0032587 | Cellular component | ruffle membrane |
GO_0070160 | Cellular component | tight junction |
GO_0043235 | Cellular component | receptor complex |
GO_0031256 | Cellular component | leading edge membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0009986 | Cellular component | cell surface |
GO_0031258 | Cellular component | lamellipodium membrane |
GO_0030027 | Cellular component | lamellipodium |
GO_0140677 | Molecular function | molecular function activator activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0005003 | Molecular function | ephrin receptor activity |
GO_0019838 | Molecular function | growth factor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EPHA2 |
Protein name | Protein tyrosine kinase Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) EPHA2 protein |
Synonyms | ECK |
Description | FUNCTION: Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis. .; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. .; FUNCTION: Acts as a receptor for human cytomegalovirus (HCMV) to mediate viral entry and fusion in glioblastoma cells. . |
Accessions | ENST00000358432.8 [P29317-1] Q8IZL0 Q96HF4 P29317 |